Evidence map›Paper›PMID 31234704›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2020

Inter-alpha inhibitor proteins attenuate lipopolysaccharide-induced blood-brain barrier disruption and downregulate circulating interleukin 6 in mice.

Aric F Logsdon, Michelle A Erickson, Xiaodi Chen, Joseph Qiu, Yow-Pin Lim, Barbara S Stonestreet, William A Banks

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Adolescent Chronic Sleep Disruption Increases Blood-Brain Barrier Permeability, but in a Time-, Region- and Sex-Dependent Manner in CD-1 Mice.International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Three-dimensional remodeling of functional cerebrovascular architecture and gliovascular unit in leptin receptor-deficient mice.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Aric F LogsdonGeriatric Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA.
Michelle A EricksonGeriatric Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA.
Xiaodi ChenDepartment of Pediatrics, Women & Infants Hospital of RI, The Alpert Medical School of Brown University, Providence, RI, USA.
Joseph QiuProThera Biologics, Inc., Providence, RI, USA.
Yow-Pin LimProThera Biologics, Inc., Providence, RI, USA.
Barbara S StonestreetDepartment of Pediatrics, Women & Infants Hospital of RI, The Alpert Medical School of Brown University, Providence, RI, USA.
William A BanksGeriatric Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA.
Brown University · USProThera Biologics (United States) · USUniversity of Puget Sound · USUniversity of Washington · US

Funding

Neurobehavior, Neuropathology, and Risk Factors in Alzheimer's DiseaseT32AG052354 · NIA · UNIVERSITY OF WASHINGTON · PI Brian C. Kraemer, ELAINE R. PESKIND · 2016 to 2026
$6.7M
FASD Inhibition of ASPH-Notch Mediates Adolescent Cerebral White Matter Pathology-Potential Utility of Non-invasive Extracellular Vesicle AssaysR01AA011431 · NIAAA · RHODE ISLAND HOSPITAL (PROVIDENCE, RI) · PI SUZANNE M. DE LA MONTE · 1996 to 2026
$5.4M
Inter-alpha Inhibitors in Hypoxic-Ischemic Brain InjuryR44NS084575 · NINDS · PROTHERA BIOLOGICS, LLC · PI LIM, YOW-PIN · 2017 to 2023
$4.7M
Cytokines and the blood-brain barrier in the ovine fetusR01HD057100 · NICHD · WOMEN AND INFANTS HOSPITAL-RHODE ISLAND · PI STONESTREET, BARBARA S · 2008 to 2020
$3.8M
Intranasal Insulin in a Mouse Model of Alzheimer's DiseaseR01AG046619 · NIA · SEATTLE INST FOR BIOMEDICAL/CLINICAL RES · PI BANKS, WILLIAM A · 2014 to 2018
$2.4M
Pathogenesis of Early- Versus Late-Stage Alcohol-Mediated White Matter DegenerationR01AA028408 · NIAAA · RHODE ISLAND HOSPITAL · PI DE LA MONTE, SUZANNE M. · 2021 to 2025
$1.7M
Beneficial Effects of Inter-alpha Inhibitors in Fetal Brain InjuryR21NS096525 · NINDS · WOMEN AND INFANTS HOSPITAL-RHODE ISLAND · PI STONESTREET, BARBARA S · 2016 to 2017
$441k
Inter-alpha inhibitors: Novel neuroinflammatory modulator of neonatal brain injuryR21NS095130 · NINDS · WOMEN AND INFANTS HOSPITAL-RHODE ISLAND · PI STONESTREET, BARBARA S · 2016 to 2017
$441k
ETHANOL, INSULIN/IGF SIGNALING AND NEURONAL MIGRATIONR56AA011431 · NIAAA · RHODE ISLAND HOSPITAL · PI DE LA MONTE, SUZANNE M. · 2008 to 2008
$312k
NIAAA NIH HHS R01 AA011431NIAAA NIH HHS R01 AA028408NIAAA NIH HHS R56 AA011431NIA NIH HHS R01 AG046619NIA NIH HHS T32 AG052354NICHD NIH HHS R01 HD057100NINDS NIH HHS R21 NS095130NINDS NIH HHS R21 NS096525NINDS NIH HHS R44 NS084575
6 · The paper itself

Abstract

Circulating levels of inter-alpha inhibitor proteins change dramatically in acute inflammatory disorders, which suggest an important contribution to the immunomodulatory system. Human blood-derived inter-alpha inhibitor proteins are neuroprotective and improve survival of neonatal mice exposed to lipopolysaccharide. Lipopolysaccharide augments inflammatory conditions and disrupts the blood-brain barrier. There is a paucity of therapeutic strategies to treat blood-brain barrier dysfunction, and the neuroprotective effects of human blood-derived inter-alpha inhibitor proteins are not fully understood. To examine the therapeutic potential of inter-alpha inhibitor proteins, we administered human blood-derived inter-alpha inhibitor proteins to male and female CD-1 mice after lipopolysaccharide exposure and quantified blood-brain barrier permeability of intravenously injected

Indexed as

Alpha-GlobulinsAnimalsBlood-Brain BarrierCapillary PermeabilityDown-RegulationFemaleHumansInflammationInterleukin-6LipopolysaccharidesMaleMiceNeuroprotective AgentsAlpha-Globulinsinter-alpha-inhibitorInterleukin-6LipopolysaccharidesNeuroprotective Agentsblood–brain barrierinflammationInter-alpha inhibitor proteinsinterleukin 6lipopolysaccharide

Identifiers

PMID31234704
PMCPMC7181088
OpenAlexW2955269702

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.